Abstract:Introduction Everolimus and sirolimus are immunosuppressants that inhibit mechanistic target of rapamycin (mTOR) used to prevent graft rejection after heart transplantation. Hypersensitivity pneumonitis is a known class effect toxicity of mTOR inhibitors. Prognosis is favorable if medication is stopped before there is extensive damage. We report two cases of hypersensitivity pneumonitis in patients receiving mTOR inhibitors. Case 1 A 45-year-old female who was 7 years S/P heart transplant for NICM presented to clinic for progressive shortness of breath for one month. Her post-transplant course was complicated by antibody-mediated rejection and allograft vasculopathy, for which mycophenolate mofetil (MMF) was substituted for everolimus 3months prior to her presentation. CT scan showed new ground glass opacities (GGO) throughout the right lung and the left lower lobe (figure 1a). An extensive infectious workup was negative. Bronchoscopy with BAL resulted in elevated polymorphonuclear leukocytes (55%), lymphocytes (4%), and macrophages (41%) with negative cultures and antigen testing. She remained hemodynamically stable on room air and was discharged on MMF instead of everolimus. After 2 months, her symptoms had improved, and repeat CT scan showed near complete resolution of prior infiltrates (Figure 1b). Case 2 A 41-year-old female who was 9 years S/P heart transplant for peripartum cardiomyopathy presented with 6 months of progressive shortness of breath and productive cough. MMF was switched to sirolimus for de novo donor-specific antibodies 6 months prior. On presentation, she was hemodynamically stable on room air. Labs were significant for WBC 20 x109/L with 48% eosinophils. CT scan showed patchy diffuse GGO (figure 2a). An extensive infectious workup was negative. Bronchoscopy with BAL showed 93% Eosinophils. The diagnosis of mTOR-induced eosinophilic pneumonitis was made, and sirolimus was stopped. She was discharged on a higher dose of MMF. Her symptoms continued to improve. Four months later, she had a repeat CT scan which showed resolution of GGO (figure 2b). Conclusion We present two cases of reversible mTOR inhibitor-induced hypersensitivity pneumonitis with full clinical and radiographic recovery with discontinuation of therapy. It is vital to screen for symptoms and recognize the diagnosis early as discontinuation of therapy can prevent significant morbidity. .

Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier

Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review

Hepatitis and Hepatitis B Virus Reactivation in Everolimus-Treated Solid Tumor Patients: A Focus on HBV-Endemic Areas

Life-Threatening Everolimus-Associated Pneumonitis: A Case Report and a Review of the Literature

Fatal acute-on-chronic liver failure following camrelizumab for hepatocellular carcinoma with HBsAg seroclearance: a case report and literature review

Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report

Fatal Hepatic Failure After Emergence of the Hepatitis B Virus Mutant During Lamivudine Therapy in a Patient with Liver Cirrhosis

De novo Hepatitis B Virus Reactivation during Treatment with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Patient with Advanced Lung Cancer

The Influence of Infection of Hepatitis B and Hepatitis C Virus on the Long-Term Survival of the Renal Transplantation Recipients

Acute-on-chronic Liver Failure in Chronic Hepatitis B: an Update.

Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma

Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation

Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report

Comprehensive Treatment of Acute-On-Chronic Liver Failure in A Patient with Hepatitis B: A Case Report

Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis

Tacrolimus-Induced Hepatic Vein Occlusive Disease After Deceased Donor Liver Transplantation: A Case Report

Everolimus And Sirolimus Hypersensitivity Pneumonitis With Full Recovery: A Case Series

A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer

A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report

Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo

Mortality associated with the development of acute liver failure after a single dose of nivolumab